AstraZeneca says EU legal action over COVID-19 vaccine supply is without merit

LONDON, April 26 (Reuters) - AstraZeneca (AZN.L) on Monday said that legal action by the European Union against the pharmaceutical company over the supply of its COVID-19 vaccine was without merit and pledged to defend itself strongly in court.

"AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will strongly defend itself in court. We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible," AstraZeneca said in a statement.

Reporting by Alistair Smout

Our Standards: The Thomson Reuters Trust Principles.